Skip to main content

Investigation of possibility to use fullerene nanoparticles in development of novel therapeutic agents against autoimmune thyroiditis

Project/agreement No.
132305
Project funding
20 000.00 EUR
Project realization
01.04.2019. - 31.03.2020.

Aim

The aim of this study is to investigate the use of fullerene nanoparticles as an opportunistic adjuvant/delivery agent for synthetic peptide vaccine development and to test fullerene antioxidant activity in thyrocytes’ acquired from patients with autoimmune thyroiditis.